title: Immune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored?
authors.affiliation: Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York 10065, USA. peralesm@mskcc.org
authors.forename: Miguel-Angel
authors.initials: MA
authors.lastname: Perales
authors.forename: Marcel R M
authors.initials: MR
authors.lastname: van den Brink
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D036101:Cord Blood Stem Cell Transplantation; D006086:Graft vs Host Disease / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D018655:Lymphocyte Count; D016131:Lymphocyte Subsets / Q000276:immunology; D020127:Recovery of Function; D015996:Survival Rate; D014184:Transplantation, Homologous